RLF Statistics
Total Valuation
Relief Therapeutics Holding has a market cap or net worth of CHF 22.95 million. The enterprise value is 14.64 million.
Market Cap | 22.95M |
Enterprise Value | 14.64M |
Important Dates
The next estimated earnings date is Tuesday, September 17, 2024.
Earnings Date | Sep 17, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Relief Therapeutics Holding has 12.54 million shares outstanding.
Shares Outstanding | 12.54M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.70% |
Owned by Institutions (%) | 15.68% |
Float | 9.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.66 |
PB Ratio | 0.47 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.32 |
EV / Sales | 1.70 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1.41 |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 4.91.
Current Ratio | 3.09 |
Quick Ratio | 2.45 |
Debt / Equity | 4.91 |
Debt / EBITDA | n/a |
Debt / FCF | -0.23 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.38% and return on invested capital (ROIC) is -10.23%.
Return on Equity (ROE) | -64.38% |
Return on Assets (ROA) | -7.83% |
Return on Capital (ROIC) | -10.23% |
Revenue Per Employee | 175,469 |
Profits Per Employee | -943,653 |
Employee Count | 49 |
Asset Turnover | 0.09 |
Inventory Turnover | 6.56 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.04% in the last 52 weeks. The beta is -14.74, so Relief Therapeutics Holding's price volatility has been lower than the market average.
Beta (5Y) | -14.74 |
52-Week Price Change | -54.04% |
50-Day Moving Average | 1.17 |
200-Day Moving Average | 1.42 |
Relative Strength Index (RSI) | 79.06 |
Average Volume (20 Days) | 36,457 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Relief Therapeutics Holding had revenue of CHF 8.60 million and -46.24 million in losses. Loss per share was -3.70.
Revenue | 8.60M |
Gross Profit | 5.90M |
Operating Income | -12.33M |
Pretax Income | -51.54M |
Net Income | -46.24M |
EBITDA | -9.81M |
EBIT | -12.33M |
Loss Per Share | -3.70 |
Balance Sheet
The company has 10.73 million in cash and 2.42 million in debt, giving a net cash position of 8.31 million or 0.66 per share.
Cash & Cash Equivalents | 10.73M |
Total Debt | 2.42M |
Net Cash | 8.31M |
Net Cash Per Share | 0.66 |
Equity (Book Value) | 49.27M |
Book Value Per Share | 3.92 |
Working Capital | 9.95M |
Cash Flow
In the last 12 months, operating cash flow was -10.31 million and capital expenditures -77,000, giving a free cash flow of -10.39 million.
Operating Cash Flow | -10.31M |
Capital Expenditures | -77,000 |
Free Cash Flow | -10.39M |
FCF Per Share | -0.83 |
Margins
Gross Margin | 68.56% |
Operating Margin | -143.38% |
Pretax Margin | -599.43% |
Profit Margin | n/a |
EBITDA Margin | -114.13% |
EBIT Margin | -143.38% |
FCF Margin | -120.83% |
Dividends & Yields
Relief Therapeutics Holding does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -202.33% |
FCF Yield | -45.27% |
Stock Splits
The last stock split was on May 5, 2023. It was a reverse split with a ratio of 0.0025.
Last Split Date | May 5, 2023 |
Split Type | Reverse |
Split Ratio | 0.0025 |